MRI characteristics of MOG-Ab associated disease in adults: An update.


Journal

Revue neurologique
ISSN: 0035-3787
Titre abrégé: Rev Neurol (Paris)
Pays: France
ID NLM: 2984779R

Informations de publication

Date de publication:
Historique:
received: 12 05 2020
revised: 20 06 2020
accepted: 23 06 2020
pubmed: 14 10 2020
medline: 7 8 2021
entrez: 13 10 2020
Statut: ppublish

Résumé

Our knowledge of the radiological spectrum of myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD) is growing rapidly. An update on the radiological features of the disease, and its evolution is thus necessary. Magnetic resonance imaging (MRI) has an increasingly important role in the differential diagnosis of MOGAD particularly from aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder (AQP4-NMOSD), and multiple sclerosis (MS). Differentiating these conditions is of prime importance because the management is different between the three inflammatory diseases, and thus could prevent further attack-related disability. Therefore, identifying the MRI features suggestive of MOGAD has diagnostic and prognostic implications. We herein review optic nerve, spinal cord and the brain MRI findings from MOGAD adult patients, and compare them to AQP4-NMOSD and MS.

Identifiants

pubmed: 33046261
pii: S0035-3787(20)30679-2
doi: 10.1016/j.neurol.2020.06.016
pii:
doi:

Substances chimiques

Aquaporin 4 0
Autoantibodies 0
Myelin-Oligodendrocyte Glycoprotein 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

39-50

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

N Shor (N)

Department of Neuroradiology, Pitié Salpêtrière Hospital, APHP, 47-83, boulevard de l'Hôpital, 75013 Paris, France. Electronic address: natalia.shor@aphp.fr.

R Deschamps (R)

Department of Neurology, Hôpital Fondation Adolphe de Rothschild Paris Paris, France.

A Cobo Calvo (A)

Centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM)- Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation-Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 6977 Lyon, France.

E Maillart (E)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

H Zephir (H)

Department of Neurology, U 1172,CRC-SEP, University Hospital of Lille, Lille, France.

J Ciron (J)

Department of Neurology, University Hospital of Purpan, Toulouse, France.

C Papeix (C)

Department of Neurology, Pitié-Salpêtrière Hospital, APHP, Paris, France.

F Durand-Dubief (F)

Centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM)- Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation-Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 6977 Lyon, France.

A Ruet (A)

Department of Neurology, Bordeaux University Hospital, Bordeaux, France.

X Ayrignac (X)

Department of Neurology, Montpellier University Hospital, Montpellier, France.

M Cohen (M)

Service de Neurologie, Université Côte d'Azur, Hôpital Pasteur 2, Nice University Hospital, Nice, France.

K Deiva (K)

National Referral Center for Neuro-Inflammatory Diseases and Pediatric Neurology Department, Kremlin-Bicêtre Hospital, Kremlin-Bicêtre, France.

D Laplaud (D)

Department of Neurology, Nantes University Hospital, Nantes, France.

B Bourre (B)

Department of Neurology, Rouen University Hospital, Rouen, France.

B Audoin (B)

Department of Neurology, Pôle de Neurosciences Cliniques, APHM, Aix Marseille University, Timone Hospital, Marseille, France.

N Collongues (N)

Department of Neurology and Clinical Investigation Center, Strasbourg University Hospital, Strasbourg, France.

S Vukusic (S)

Centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM)- Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation-Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 6977 Lyon, France.

F Cotton (F)

Department of Radiology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, 69310 Pierre-Bénite, France.

R Marignier (R)

Centre de référence des maladies inflammatoires rares du cerveau et de la moelle (MIRCEM)- Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation-Hôpital Neurologique Pierre Wertheimer Hospices Civils de Lyon, 6977 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH